Pulmonary hypertension in systemic sclerosis determines cardiac autonomic dysfunction assessed by heart rate turbulence

International Journal of Cardiology

Volumn 141, Issue 3, 2010, Pages 322-325

  Bienias, Piotr ^a   Ciurzyński, Michał ^a   Korczak, Dariusz ^a   Jankowski, Krzysztof ^a   Glińska Wielochowska, Maria ^a   Liszewska Pfejfer, Danuta ^a   Gliński, Wiesław ^a   Pruszczyk, Piotr ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Cardiac autonomic dysfunction; Heart rate turbulence; Pulmonary hypertension; Systemic sclerosis

Indexed keywords

ADULT; AGE; ARTICLE; AUTONOMIC DYSFUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART RATE; HEART RATE TURBULENCE; HOLTER MONITORING; HUMAN; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SYSTEMIC SCLEROSIS;

ADULT; AGED; AUTONOMIC NERVOUS SYSTEM DISEASES; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HEART; HEART RATE; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; SCLERODERMA, SYSTEMIC;

EID: 77952742886     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.11.093     Document Type: Article

References (17)

1. Proudman S.M., Stevens W.M., Sahhar J., and Celermajer D. Pulmonary arterial hypertension in systemic sclerosis: the need for early detection and treatment. Intern Med J 37 (2007) 485-494
2. Steen V.D., and Medsger T.A. Changes in causes of death in systemic sclerosis. 1972-2002. Ann Rheum Dis 66 (2007) 940-944
3. Guzik P., and Schmidt G. Clinical significance of heart rate turbulence. Kardiol Pol 64 (2006) 198-207
4. Arya A., Haghjoo M., and Sadr-Ameli M.A. Risk stratification for arrhythmic death after myocardial infarction: current perspective and future direction. Int J Cardiol 108 (2006) 155-164
5. Galie N., Torbicki A., Barst R., et al. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J 25 (2004) 2243-2278
6. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J 17 (1996) 354-381
7. Ferri C., Emdin M., Giuggioli D., et al. Autonomic dysfunction in systemic sclerosis: time and frequency domain 24 hour heart rate variability analysis. Br J Rheumatol 36 (1997) 669-676
8. Di Franco M., Paradiso M., Riccieri V., Basili S., Mammarella A., and Valesini G. Autonomic dysfunction and microvascular damage in systemic sclerosis. Clin Rheumatol 26 (2007) 1278-1283
9. Fauchier L., Babuty D., Melin A., Bonnet P., Cosnay P., and Paul F.J. Heart rate variability in severe right or left heart failure: the role of pulmonary hypertension and resistances. Eur J Heart Fail 6 (2004) 181-185
10. Chazova I.E., Irodova N.L., Krasnikova T.L., et al. Primary pulmonary hypertension: activation of sympathico-adrenal system and free radical oxidation. Positive effects of carvedilol therapy. Ter Arkh 77 (2005) 66-72
11. Rosas-Peralta M., Sandoval-Zarate J., Attie F., et al. Clinical implications and prognostic significance of the study on the circadian variation of heart rate variability in patients with severe pulmonary hypertension. Gac Med Mex 142 (2006) 19-28
12. Zipes D.P., Camm A.J., Borggrefe M., et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death - executive summary. Eur Heart J 27 (2006) 2099-2140
13. Schannwell C.M., Steiner S., and Strauer B.E. Diagnostics in pulmonary hypertension. J Physiol Pharmacol 58 Suppl 5 (2007) 591-602
14. Hsu V.M., Moreyra A.E., Wilson A.C., et al. Assessment of pulmonary arterial hypertension in patients with systemic sclerosis: comparison of noninvasive tests with results of right-heart catheterization. J Rheumatol 35 (2008) 458-465
15. Allanore Y., Borderie D., Meune C., et al. N-terminal pro-brain natriuretic peptide as a diagnostic marker of early pulmonary artery hypertension in patients with systemic sclerosis and effects of calcium-channel blockers. Arthritis Rheum 48 (2003) 3503-3508
16. Williams M.H., Handler C.E., Akram R., et al. Role of N-terminal brain natriuretic peptide (NT-proBNP) in scleroderma-associated pulmonary arterial hypertension. Eur Heart J 27 (2006) 1485-1494
17. Dimitroulas T., Giannakoulas G., Karvounis H., et al. Neurohormonal activation in patients with systemic sclerosis-related pulmonary arterial hypertension. Int J Cardiol 121 (2007) 135-137